跳至主要内容
临床试验/ACTRN12624000590561
ACTRN12624000590561已完成Unknown

Randomised Controlled Trial on 360° Phototherapy versus Single Surface LED Phototherapy in Neonatal Hyperbilirubinemia

niversiti Sains Malaysia0 个研究点目标入组 40 人开始时间: 2024年5月9日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 7 Days(—)
性别
All

入选标准

  • The study will include all term neonates who are born at 35 weeks of age or more, and age less than or equal to 7 days, with unconjugated hyperbilirubinemia, requiring intensive phototherapy following the Malaysian guideline of neonatal jaundice. The neonates weight must be 2 kg or more and has not received any phototherapy before.

排除标准

  • Neonates whose serum bilirubin level is above the exchange transfusion level following the Malaysian guideline of neonatal jaundice will not be included in the study. Other exclusion criterias include direct hyperbilirubinemia of >15%, neonates with congenital abnormalities or inborn error of metabolism and neonates who required intensive care.

研究者

发起方
niversiti Sains Malaysia

相似试验